247 related articles for article (PubMed ID: 15561451)
1. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
[TBL] [Abstract][Full Text] [Related]
3. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
4. [The impact exerted by the severity of recreational drug abuse on the different components of the executive function].
Verdejo A; Orozco-Giménez C; Meersmans Sánchez-Jofré M; Aguilar de Arcos F; Pérez-García M
Rev Neurol; 2004 Jun 16-30; 38(12):1109-16. PubMed ID: 15229821
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
6. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
[TBL] [Abstract][Full Text] [Related]
7. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities.
Fernández-Serrano MJ; Pérez-García M; Perales JC; Verdejo-García A
Eur J Pharmacol; 2010 Jan; 626(1):104-12. PubMed ID: 19836375
[TBL] [Abstract][Full Text] [Related]
10. Verbal working memory deficits in current and previous users of MDMA.
Wareing M; Fisk JE; Murphy P; Montgomery C
Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
[TBL] [Abstract][Full Text] [Related]
11. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Lamers CT; Bechara A; Rizzo M; Ramaekers JG
J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
[TBL] [Abstract][Full Text] [Related]
12. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
Dafters RI
Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
[TBL] [Abstract][Full Text] [Related]
13. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
Piechatzek M; Indlekofer F; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
Hum Psychopharmacol; 2009 Dec; 24(8):650-65. PubMed ID: 19946940
[TBL] [Abstract][Full Text] [Related]
14. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.
Verdejo-García A; Pérez-García M
Psychopharmacology (Berl); 2007 Mar; 190(4):517-30. PubMed ID: 17136401
[TBL] [Abstract][Full Text] [Related]
15. Effects of executive impairments on maladaptive explanatory styles in substance abusers: clinical implications.
García AV; Torrecillas FL; de Arcos FA; García MP
Arch Clin Neuropsychol; 2005 Jan; 20(1):67-80. PubMed ID: 15620814
[TBL] [Abstract][Full Text] [Related]
16. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
17. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
Lundqvist T
Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
[TBL] [Abstract][Full Text] [Related]
18. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
19. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Bedi G; Redman J
Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
[TBL] [Abstract][Full Text] [Related]
20. Drug-related decrease in neuropsychological functions of abstinent drug users.
van Holst RJ; Schilt T
Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
